nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ABCB1—Naltrexone—alcohol dependence	0.178	0.382	CbGbCtD
Canagliflozin—ABCB1—Citalopram—alcohol dependence	0.118	0.253	CbGbCtD
Canagliflozin—CYP3A4—Disulfiram—alcohol dependence	0.0992	0.213	CbGbCtD
Canagliflozin—CYP3A4—Citalopram—alcohol dependence	0.0707	0.152	CbGbCtD
Canagliflozin—ORM1—bile—alcohol dependence	0.0157	0.13	CbGeAlD
Canagliflozin—ABCC2—bile—alcohol dependence	0.0129	0.107	CbGeAlD
Canagliflozin—ORM1—saliva—alcohol dependence	0.0103	0.085	CbGeAlD
Canagliflozin—Rash papular—Naltrexone—alcohol dependence	0.00927	0.0394	CcSEcCtD
Canagliflozin—Sunburn—Citalopram—alcohol dependence	0.00724	0.0308	CcSEcCtD
Canagliflozin—Diuresis—Citalopram—alcohol dependence	0.00706	0.03	CcSEcCtD
Canagliflozin—SLC5A2—blood—alcohol dependence	0.00651	0.054	CbGeAlD
Canagliflozin—Micturition urgency—Acamprosate—alcohol dependence	0.00643	0.0273	CcSEcCtD
Canagliflozin—Fracture—Acamprosate—alcohol dependence	0.00628	0.0267	CcSEcCtD
Canagliflozin—Multiple fractures—Acamprosate—alcohol dependence	0.00628	0.0267	CcSEcCtD
Canagliflozin—Dizziness postural—Citalopram—alcohol dependence	0.00626	0.0266	CcSEcCtD
Canagliflozin—SLC5A1—cardiovascular system—alcohol dependence	0.00624	0.0517	CbGeAlD
Canagliflozin—UGT2B4—cardiovascular system—alcohol dependence	0.00575	0.0477	CbGeAlD
Canagliflozin—SLC5A2—endocrine gland—alcohol dependence	0.00565	0.0468	CbGeAlD
Canagliflozin—SLC5A2—testis—alcohol dependence	0.00539	0.0447	CbGeAlD
Canagliflozin—SLC5A1—digestive system—alcohol dependence	0.00518	0.043	CbGeAlD
Canagliflozin—Rash pustular—Acamprosate—alcohol dependence	0.00457	0.0195	CcSEcCtD
Canagliflozin—Vulvovaginal candidiasis—Citalopram—alcohol dependence	0.00416	0.0177	CcSEcCtD
Canagliflozin—SLC5A1—testis—alcohol dependence	0.00408	0.0338	CbGeAlD
Canagliflozin—Vulvovaginal mycotic infection—Citalopram—alcohol dependence	0.004	0.017	CcSEcCtD
Canagliflozin—UGT2B4—endocrine gland—alcohol dependence	0.00395	0.0327	CbGeAlD
Canagliflozin—Nocturia—Acamprosate—alcohol dependence	0.00393	0.0167	CcSEcCtD
Canagliflozin—Micturition urgency—Citalopram—alcohol dependence	0.00385	0.0164	CcSEcCtD
Canagliflozin—UGT2B4—liver—alcohol dependence	0.00356	0.0295	CbGeAlD
Canagliflozin—Vaginal infection—Acamprosate—alcohol dependence	0.00344	0.0146	CcSEcCtD
Canagliflozin—Rash maculo-papular—Acamprosate—alcohol dependence	0.00332	0.0141	CcSEcCtD
Canagliflozin—Urine output increased—Acamprosate—alcohol dependence	0.0033	0.014	CcSEcCtD
Canagliflozin—UGT1A9—digestive system—alcohol dependence	0.00326	0.027	CbGeAlD
Canagliflozin—Diabetes mellitus—Acamprosate—alcohol dependence	0.00304	0.0129	CcSEcCtD
Canagliflozin—Polyuria—Acamprosate—alcohol dependence	0.00302	0.0128	CcSEcCtD
Canagliflozin—Renal failure acute—Acamprosate—alcohol dependence	0.00287	0.0122	CcSEcCtD
Canagliflozin—Rash erythematous—Citalopram—alcohol dependence	0.00286	0.0121	CcSEcCtD
Canagliflozin—Thirst—Acamprosate—alcohol dependence	0.00278	0.0118	CcSEcCtD
Canagliflozin—Rash pustular—Citalopram—alcohol dependence	0.00274	0.0117	CcSEcCtD
Canagliflozin—UGT1A9—endocrine gland—alcohol dependence	0.0027	0.0223	CbGeAlD
Canagliflozin—Thirst—Naltrexone—alcohol dependence	0.00263	0.0112	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—ADH4—alcohol dependence	0.00255	0.0143	CbGpPWpGaD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00253	0.0142	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Acamprosate—alcohol dependence	0.00248	0.0105	CcSEcCtD
Canagliflozin—UGT1A9—liver—alcohol dependence	0.00243	0.0201	CbGeAlD
Canagliflozin—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00242	0.0103	CcSEcCtD
Canagliflozin—Breast disorder—Acamprosate—alcohol dependence	0.00239	0.0102	CcSEcCtD
Canagliflozin—Nocturia—Citalopram—alcohol dependence	0.00236	0.01	CcSEcCtD
Canagliflozin—Dehydration—Naltrexone—alcohol dependence	0.00233	0.00991	CcSEcCtD
Canagliflozin—Fatigue—Disulfiram—alcohol dependence	0.00228	0.00969	CcSEcCtD
Canagliflozin—Pancreatitis—Acamprosate—alcohol dependence	0.00224	0.00954	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—ADH7—alcohol dependence	0.00217	0.0122	CbGpPWpGaD
Canagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.00214	0.012	CbGpPWpGaD
Canagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.00214	0.012	CbGpPWpGaD
Canagliflozin—Cystitis noninfective—Citalopram—alcohol dependence	0.00214	0.00908	CcSEcCtD
Canagliflozin—Pollakiuria—Acamprosate—alcohol dependence	0.00211	0.00899	CcSEcCtD
Canagliflozin—Cystitis—Citalopram—alcohol dependence	0.00211	0.00898	CcSEcCtD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0021	0.0118	CbGpPWpGaD
Canagliflozin—Photosensitivity reaction—Acamprosate—alcohol dependence	0.00209	0.00888	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—GGT2—alcohol dependence	0.00208	0.0117	CbGpPWpGaD
Canagliflozin—Vaginal infection—Citalopram—alcohol dependence	0.00206	0.00878	CcSEcCtD
Canagliflozin—Rash maculo-papular—Citalopram—alcohol dependence	0.00199	0.00845	CcSEcCtD
Canagliflozin—Urinary tract infection—Acamprosate—alcohol dependence	0.00198	0.00844	CcSEcCtD
Canagliflozin—Urine output increased—Citalopram—alcohol dependence	0.00198	0.00841	CcSEcCtD
Canagliflozin—Bladder pain—Citalopram—alcohol dependence	0.00198	0.00841	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—ADH1B—alcohol dependence	0.0019	0.0107	CbGpPWpGaD
Canagliflozin—Asthenia—Disulfiram—alcohol dependence	0.0019	0.00806	CcSEcCtD
Canagliflozin—Urinary tract infection—Naltrexone—alcohol dependence	0.00188	0.00798	CcSEcCtD
Canagliflozin—Diabetes mellitus—Citalopram—alcohol dependence	0.00183	0.00776	CcSEcCtD
Canagliflozin—Polyuria—Citalopram—alcohol dependence	0.00181	0.00769	CcSEcCtD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00179	0.01	CbGpPWpGaD
Canagliflozin—Dizziness—Disulfiram—alcohol dependence	0.00175	0.00743	CcSEcCtD
Canagliflozin—SLC5A2—NRF2 pathway—SLC6A4—alcohol dependence	0.00173	0.00971	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—SLC6A4—alcohol dependence	0.00173	0.00971	CbGpPWpGaD
Canagliflozin—Renal failure acute—Citalopram—alcohol dependence	0.00172	0.00731	CcSEcCtD
Canagliflozin—UGT2B4—Phase II conjugation—GGT1—alcohol dependence	0.00168	0.00944	CbGpPWpGaD
Canagliflozin—Thirst—Citalopram—alcohol dependence	0.00167	0.00709	CcSEcCtD
Canagliflozin—Rash—Disulfiram—alcohol dependence	0.00167	0.00708	CcSEcCtD
Canagliflozin—ORM1—blood—alcohol dependence	0.00164	0.0136	CbGeAlD
Canagliflozin—Hypoglycaemia—Citalopram—alcohol dependence	0.00163	0.00692	CcSEcCtD
Canagliflozin—Malnutrition—Acamprosate—alcohol dependence	0.00159	0.00678	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—MAOB—alcohol dependence	0.00158	0.00885	CbGpPWpGaD
Canagliflozin—Angiopathy—Naltrexone—alcohol dependence	0.00157	0.00669	CcSEcCtD
Canagliflozin—SLC5A1—NRF2 pathway—SLC6A3—alcohol dependence	0.00154	0.00865	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—SLC6A3—alcohol dependence	0.00154	0.00865	CbGpPWpGaD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00152	0.00851	CbGpPWpGaD
Canagliflozin—ALB—Transport of organic anions—AVP—alcohol dependence	0.00151	0.00847	CbGpPWpGaD
Canagliflozin—Malnutrition—Naltrexone—alcohol dependence	0.00151	0.00642	CcSEcCtD
Canagliflozin—Dehydration—Citalopram—alcohol dependence	0.00148	0.00628	CcSEcCtD
Canagliflozin—Angioedema—Acamprosate—alcohol dependence	0.00146	0.0062	CcSEcCtD
Canagliflozin—SLC5A2—NRF2 pathway—GGT1—alcohol dependence	0.00145	0.00815	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—GGT1—alcohol dependence	0.00145	0.00815	CbGpPWpGaD
Canagliflozin—Orthostatic hypotension—Citalopram—alcohol dependence	0.00145	0.00617	CcSEcCtD
Canagliflozin—Breast disorder—Citalopram—alcohol dependence	0.00143	0.0061	CcSEcCtD
Canagliflozin—Syncope—Acamprosate—alcohol dependence	0.00143	0.00608	CcSEcCtD
Canagliflozin—UGT1A9—NRF2 pathway—ALDH3A1—alcohol dependence	0.00142	0.00797	CbGpPWpGaD
Canagliflozin—ORM1—endocrine gland—alcohol dependence	0.00142	0.0118	CbGeAlD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00142	0.00794	CbGpPWpGaD
Canagliflozin—ABCC2—digestive system—alcohol dependence	0.00141	0.0117	CbGeAlD
Canagliflozin—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00141	0.00789	CbGpPWpGaD
Canagliflozin—Loss of consciousness—Acamprosate—alcohol dependence	0.0014	0.00596	CcSEcCtD
Canagliflozin—ABCC2—NRF2 pathway—ALDH3A1—alcohol dependence	0.00139	0.00778	CbGpPWpGaD
Canagliflozin—Convulsion—Acamprosate—alcohol dependence	0.00138	0.00588	CcSEcCtD
Canagliflozin—Angioedema—Naltrexone—alcohol dependence	0.00138	0.00586	CcSEcCtD
Canagliflozin—Syncope—Naltrexone—alcohol dependence	0.00135	0.00575	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00135	0.00573	CcSEcCtD
Canagliflozin—Pancreatitis—Citalopram—alcohol dependence	0.00135	0.00572	CcSEcCtD
Canagliflozin—ABCC2—blood—alcohol dependence	0.00134	0.0111	CbGeAlD
Canagliflozin—UGT2B4—Biological oxidations—ALDH2—alcohol dependence	0.00134	0.00752	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—ADH6—alcohol dependence	0.00134	0.00752	CbGpPWpGaD
Canagliflozin—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00134	0.00749	CbGpPWpGaD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00133	0.00746	CbGpPWpGaD
Canagliflozin—Dry mouth—Acamprosate—alcohol dependence	0.00133	0.00565	CcSEcCtD
Canagliflozin—ORM1—nervous system—alcohol dependence	0.00133	0.011	CbGeAlD
Canagliflozin—Loss of consciousness—Naltrexone—alcohol dependence	0.00133	0.00564	CcSEcCtD
Canagliflozin—UGT1A9—Phase II conjugation—GGT2—alcohol dependence	0.00132	0.00738	CbGpPWpGaD
Canagliflozin—Convulsion—Naltrexone—alcohol dependence	0.00131	0.00556	CcSEcCtD
Canagliflozin—Infection—Acamprosate—alcohol dependence	0.00129	0.0055	CcSEcCtD
Canagliflozin—Shock—Acamprosate—alcohol dependence	0.00128	0.00545	CcSEcCtD
Canagliflozin—ORM1—liver—alcohol dependence	0.00128	0.0106	CbGeAlD
Canagliflozin—ORM1—central nervous system—alcohol dependence	0.00128	0.0106	CbGeAlD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00128	0.00542	CcSEcCtD
Canagliflozin—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00127	0.00711	CbGpPWpGaD
Canagliflozin—Pollakiuria—Citalopram—alcohol dependence	0.00127	0.00539	CcSEcCtD
Canagliflozin—Skin disorder—Acamprosate—alcohol dependence	0.00126	0.00538	CcSEcCtD
Canagliflozin—Dry mouth—Naltrexone—alcohol dependence	0.00126	0.00534	CcSEcCtD
Canagliflozin—Photosensitivity reaction—Citalopram—alcohol dependence	0.00125	0.00533	CcSEcCtD
Canagliflozin—Infection—Naltrexone—alcohol dependence	0.00122	0.0052	CcSEcCtD
Canagliflozin—Hypotension—Acamprosate—alcohol dependence	0.00122	0.00517	CcSEcCtD
Canagliflozin—Shock—Naltrexone—alcohol dependence	0.00121	0.00515	CcSEcCtD
Canagliflozin—Nervous system disorder—Naltrexone—alcohol dependence	0.00121	0.00514	CcSEcCtD
Canagliflozin—Skin disorder—Naltrexone—alcohol dependence	0.0012	0.00509	CcSEcCtD
Canagliflozin—Urinary tract infection—Citalopram—alcohol dependence	0.00119	0.00506	CcSEcCtD
Canagliflozin—ALB—testis—alcohol dependence	0.00119	0.00983	CbGeAlD
Canagliflozin—ABCC2—endocrine gland—alcohol dependence	0.00117	0.00966	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00112	0.00478	CcSEcCtD
Canagliflozin—ALB—liver—alcohol dependence	0.00112	0.00929	CbGeAlD
Canagliflozin—Constipation—Acamprosate—alcohol dependence	0.00111	0.00473	CcSEcCtD
Canagliflozin—ABCC2—testis—alcohol dependence	0.00111	0.00921	CbGeAlD
Canagliflozin—UGT1A9—Biological oxidations—ADH1A—alcohol dependence	0.00111	0.00623	CbGpPWpGaD
Canagliflozin—Urinary tract disorder—Citalopram—alcohol dependence	0.00108	0.00461	CcSEcCtD
Canagliflozin—Urethral disorder—Citalopram—alcohol dependence	0.00108	0.00458	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—CYP2E1—alcohol dependence	0.00107	0.00601	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT2—alcohol dependence	0.00106	0.00597	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT2—alcohol dependence	0.00106	0.00597	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00106	0.00453	CcSEcCtD
Canagliflozin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00106	0.00452	CcSEcCtD
Canagliflozin—Fatigue—Naltrexone—alcohol dependence	0.00106	0.00451	CcSEcCtD
Canagliflozin—UGT2B4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00106	0.00593	CbGpPWpGaD
Canagliflozin—Constipation—Naltrexone—alcohol dependence	0.00105	0.00448	CcSEcCtD
Canagliflozin—ABCC2—liver—alcohol dependence	0.00105	0.00871	CbGeAlD
Canagliflozin—Urticaria—Acamprosate—alcohol dependence	0.00103	0.0044	CcSEcCtD
Canagliflozin—Abdominal pain—Acamprosate—alcohol dependence	0.00103	0.00438	CcSEcCtD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00103	0.00576	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00103	0.00576	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00101	0.00428	CcSEcCtD
Canagliflozin—Angiopathy—Citalopram—alcohol dependence	0.000997	0.00424	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—GGT1—alcohol dependence	0.000984	0.00552	CbGpPWpGaD
Canagliflozin—Urticaria—Naltrexone—alcohol dependence	0.000978	0.00416	CcSEcCtD
Canagliflozin—Abdominal pain—Naltrexone—alcohol dependence	0.000974	0.00414	CcSEcCtD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000972	0.00545	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000972	0.00545	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Acamprosate—alcohol dependence	0.000959	0.00408	CcSEcCtD
Canagliflozin—Erythema—Citalopram—alcohol dependence	0.000956	0.00407	CcSEcCtD
Canagliflozin—Malnutrition—Citalopram—alcohol dependence	0.000956	0.00407	CcSEcCtD
Canagliflozin—UGT1A9—Biological oxidations—ADH4—alcohol dependence	0.000945	0.0053	CbGpPWpGaD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000938	0.00526	CbGpPWpGaD
Canagliflozin—Asthenia—Acamprosate—alcohol dependence	0.000934	0.00397	CcSEcCtD
Canagliflozin—Pruritus—Acamprosate—alcohol dependence	0.000921	0.00392	CcSEcCtD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT1—alcohol dependence	0.000919	0.00515	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT1—alcohol dependence	0.000919	0.00515	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—ADH7—alcohol dependence	0.000916	0.00514	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Naltrexone—alcohol dependence	0.000907	0.00386	CcSEcCtD
Canagliflozin—ABCC2—NRF2 pathway—ADH7—alcohol dependence	0.000894	0.00501	CbGpPWpGaD
Canagliflozin—ALB—brain—alcohol dependence	0.00089	0.00737	CbGeAlD
Canagliflozin—Asthenia—Naltrexone—alcohol dependence	0.000884	0.00376	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—MAOA—alcohol dependence	0.000882	0.00495	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—GGT2—alcohol dependence	0.000878	0.00492	CbGpPWpGaD
Canagliflozin—Angioedema—Citalopram—alcohol dependence	0.000874	0.00371	CcSEcCtD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000873	0.00489	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000873	0.00489	CbGpPWpGaD
Canagliflozin—Pruritus—Naltrexone—alcohol dependence	0.000871	0.0037	CcSEcCtD
Canagliflozin—Dizziness—Acamprosate—alcohol dependence	0.000861	0.00366	CcSEcCtD
Canagliflozin—Syncope—Citalopram—alcohol dependence	0.000857	0.00365	CcSEcCtD
Canagliflozin—ABCC2—NRF2 pathway—GGT2—alcohol dependence	0.000857	0.0048	CbGpPWpGaD
Canagliflozin—Loss of consciousness—Citalopram—alcohol dependence	0.00084	0.00357	CcSEcCtD
Canagliflozin—Convulsion—Citalopram—alcohol dependence	0.000828	0.00352	CcSEcCtD
Canagliflozin—Rash—Acamprosate—alcohol dependence	0.000821	0.00349	CcSEcCtD
Canagliflozin—Dermatitis—Acamprosate—alcohol dependence	0.00082	0.00349	CcSEcCtD
Canagliflozin—Dizziness—Naltrexone—alcohol dependence	0.000814	0.00346	CcSEcCtD
Canagliflozin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000808	0.00344	CcSEcCtD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000804	0.00451	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000804	0.00451	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—ADH7—alcohol dependence	0.000803	0.00451	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADH6—alcohol dependence	0.000803	0.0045	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADH6—alcohol dependence	0.000803	0.0045	CbGpPWpGaD
Canagliflozin—Dry mouth—Citalopram—alcohol dependence	0.000796	0.00338	CcSEcCtD
Canagliflozin—Rash—Naltrexone—alcohol dependence	0.000777	0.0033	CcSEcCtD
Canagliflozin—Dermatitis—Naltrexone—alcohol dependence	0.000776	0.0033	CcSEcCtD
Canagliflozin—Infection—Citalopram—alcohol dependence	0.000775	0.0033	CcSEcCtD
Canagliflozin—Nausea—Acamprosate—alcohol dependence	0.000773	0.00329	CcSEcCtD
Canagliflozin—UGT1A9—Biological oxidations—GGT2—alcohol dependence	0.00077	0.00432	CbGpPWpGaD
Canagliflozin—Shock—Citalopram—alcohol dependence	0.000768	0.00326	CcSEcCtD
Canagliflozin—Nervous system disorder—Citalopram—alcohol dependence	0.000765	0.00325	CcSEcCtD
Canagliflozin—Skin disorder—Citalopram—alcohol dependence	0.000758	0.00322	CcSEcCtD
Canagliflozin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00075	0.0042	CbGpPWpGaD
Canagliflozin—Nausea—Naltrexone—alcohol dependence	0.000732	0.00311	CcSEcCtD
Canagliflozin—Hypotension—Citalopram—alcohol dependence	0.000729	0.0031	CcSEcCtD
Canagliflozin—ABCB1—forebrain—alcohol dependence	0.000723	0.00599	CbGeAlD
Canagliflozin—CYP3A4—digestive system—alcohol dependence	0.000716	0.00594	CbGeAlD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000714	0.004	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—ADH1B—alcohol dependence	0.000704	0.00395	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—GGT2—alcohol dependence	0.000689	0.00387	CbGpPWpGaD
Canagliflozin—CYP3A4—blood—alcohol dependence	0.000683	0.00566	CbGeAlD
Canagliflozin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000674	0.00286	CcSEcCtD
Canagliflozin—Fatigue—Citalopram—alcohol dependence	0.000673	0.00286	CcSEcCtD
Canagliflozin—ABCB1—adrenal cortex—alcohol dependence	0.000669	0.00555	CbGeAlD
Canagliflozin—Constipation—Citalopram—alcohol dependence	0.000667	0.00284	CcSEcCtD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000666	0.00373	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADH1A—alcohol dependence	0.000665	0.00373	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADH1A—alcohol dependence	0.000665	0.00373	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Citalopram—alcohol dependence	0.000638	0.00271	CcSEcCtD
Canagliflozin—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000627	0.00352	CbGpPWpGaD
Canagliflozin—UGT1A9—Phase II conjugation—GGT1—alcohol dependence	0.000623	0.00349	CbGpPWpGaD
Canagliflozin—Urticaria—Citalopram—alcohol dependence	0.00062	0.00264	CcSEcCtD
Canagliflozin—UGT2B4—Metabolism—ADH6—alcohol dependence	0.00062	0.00348	CbGpPWpGaD
Canagliflozin—Abdominal pain—Citalopram—alcohol dependence	0.000617	0.00262	CcSEcCtD
Canagliflozin—ABCB1—cardiovascular system—alcohol dependence	0.000611	0.00506	CbGeAlD
Canagliflozin—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000603	0.00338	CbGpPWpGaD
Canagliflozin—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.0006	0.00336	CbGpPWpGaD
Canagliflozin—ABCB1—pancreas—alcohol dependence	0.000594	0.00492	CbGeAlD
Canagliflozin—CYP3A4—endocrine gland—alcohol dependence	0.000592	0.00491	CbGeAlD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000591	0.00332	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—MAOB—alcohol dependence	0.000584	0.00327	CbGpPWpGaD
Canagliflozin—Hypersensitivity—Citalopram—alcohol dependence	0.000575	0.00244	CcSEcCtD
Canagliflozin—UGT2B4—Biological oxidations—POMC—alcohol dependence	0.000574	0.00322	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADH4—alcohol dependence	0.000565	0.00317	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADH4—alcohol dependence	0.000565	0.00317	CbGpPWpGaD
Canagliflozin—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—alcohol dependence	0.00056	0.00314	CbGpPWpGaD
Canagliflozin—Asthenia—Citalopram—alcohol dependence	0.00056	0.00238	CcSEcCtD
Canagliflozin—ABCB1—gonad—alcohol dependence	0.000554	0.0046	CbGeAlD
Canagliflozin—CYP3A4—nervous system—alcohol dependence	0.000554	0.00459	CbGeAlD
Canagliflozin—Pruritus—Citalopram—alcohol dependence	0.000552	0.00235	CcSEcCtD
Canagliflozin—CYP3A4—liver—alcohol dependence	0.000534	0.00442	CbGeAlD
Canagliflozin—CYP3A4—central nervous system—alcohol dependence	0.000533	0.00442	CbGeAlD
Canagliflozin—Dizziness—Citalopram—alcohol dependence	0.000516	0.00219	CcSEcCtD
Canagliflozin—UGT2B4—Metabolism—ADH1A—alcohol dependence	0.000513	0.00288	CbGpPWpGaD
Canagliflozin—ABCB1—digestive system—alcohol dependence	0.000507	0.0042	CbGeAlD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000503	0.00282	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—ALDH2—alcohol dependence	0.000496	0.00278	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—SLC6A4—alcohol dependence	0.000495	0.00277	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000494	0.00277	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000494	0.00277	CbGpPWpGaD
Canagliflozin—Rash—Citalopram—alcohol dependence	0.000492	0.00209	CcSEcCtD
Canagliflozin—Dermatitis—Citalopram—alcohol dependence	0.000492	0.00209	CcSEcCtD
Canagliflozin—ABCB1—blood—alcohol dependence	0.000483	0.004	CbGeAlD
Canagliflozin—ABCC2—NRF2 pathway—SLC6A4—alcohol dependence	0.000483	0.00271	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADH7—alcohol dependence	0.000481	0.0027	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADH7—alcohol dependence	0.000481	0.0027	CbGpPWpGaD
Canagliflozin—ABCB1—midbrain—alcohol dependence	0.000477	0.00395	CbGeAlD
Canagliflozin—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000474	0.00266	CbGpPWpGaD
Canagliflozin—Nausea—Citalopram—alcohol dependence	0.000464	0.00197	CcSEcCtD
Canagliflozin—SLC5A1—Metabolism—GGT2—alcohol dependence	0.000461	0.00259	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GGT2—alcohol dependence	0.000461	0.00259	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—SLC6A3—alcohol dependence	0.000441	0.00247	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ADH4—alcohol dependence	0.000437	0.00245	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—SLC6A3—alcohol dependence	0.00043	0.00241	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000427	0.0024	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ADH1B—alcohol dependence	0.000422	0.00236	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ADH1B—alcohol dependence	0.000422	0.00236	CbGpPWpGaD
Canagliflozin—ABCB1—endocrine gland—alcohol dependence	0.000419	0.00347	CbGeAlD
Canagliflozin—UGT1A9—NRF2 pathway—GGT1—alcohol dependence	0.000415	0.00233	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00041	0.0023	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000409	0.00229	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000409	0.00229	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—GGT1—alcohol dependence	0.000405	0.00227	CbGpPWpGaD
Canagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000405	0.00227	CbGpPWpGaD
Canagliflozin—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000403	0.00226	CbGpPWpGaD
Canagliflozin—ABCB1—testis—alcohol dependence	0.0004	0.00331	CbGeAlD
Canagliflozin—UGT1A9—Biological oxidations—CYP2E1—alcohol dependence	0.000397	0.00223	CbGpPWpGaD
Canagliflozin—ABCB1—nervous system—alcohol dependence	0.000392	0.00325	CbGeAlD
Canagliflozin—UGT1A9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000391	0.00219	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000379	0.00213	CbGpPWpGaD
Canagliflozin—ABCB1—liver—alcohol dependence	0.000378	0.00313	CbGeAlD
Canagliflozin—ABCB1—central nervous system—alcohol dependence	0.000378	0.00313	CbGeAlD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000375	0.0021	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ADH7—alcohol dependence	0.000371	0.00208	CbGpPWpGaD
Canagliflozin—ABCB1—cerebellum—alcohol dependence	0.000369	0.00306	CbGeAlD
Canagliflozin—UGT1A9—Biological oxidations—GGT1—alcohol dependence	0.000364	0.00204	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GGT2—alcohol dependence	0.000356	0.002	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MAOB—alcohol dependence	0.000349	0.00196	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MAOB—alcohol dependence	0.000349	0.00196	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—MAOA—alcohol dependence	0.000326	0.00183	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000326	0.00183	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ADH1B—alcohol dependence	0.000326	0.00183	CbGpPWpGaD
Canagliflozin—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000322	0.00181	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000314	0.00176	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000311	0.00174	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT2—alcohol dependence	0.000302	0.00169	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT2—alcohol dependence	0.000302	0.00169	CbGpPWpGaD
Canagliflozin—ABCB1—brain—alcohol dependence	0.0003	0.00248	CbGeAlD
Canagliflozin—SLC5A2—Metabolism—ALDH2—alcohol dependence	0.000297	0.00167	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ALDH2—alcohol dependence	0.000297	0.00167	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000286	0.00161	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MAOB—alcohol dependence	0.00027	0.00151	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000267	0.0015	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000264	0.00148	CbGpPWpGaD
Canagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00026	0.00146	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT1—alcohol dependence	0.00026	0.00146	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT1—alcohol dependence	0.00026	0.00146	CbGpPWpGaD
Canagliflozin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000257	0.00144	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT2—alcohol dependence	0.000253	0.00142	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT2—alcohol dependence	0.000253	0.00142	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000243	0.00136	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—CYP2E1—alcohol dependence	0.000237	0.00133	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—CYP2E1—alcohol dependence	0.000237	0.00133	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADH6—alcohol dependence	0.000229	0.00129	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ALDH2—alcohol dependence	0.000229	0.00129	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000227	0.00127	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GGT1—alcohol dependence	0.000218	0.00122	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT1—alcohol dependence	0.000218	0.00122	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GGT1—alcohol dependence	0.000218	0.00122	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT1—alcohol dependence	0.000218	0.00122	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000218	0.00122	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—POMC—alcohol dependence	0.000213	0.00119	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000211	0.00118	CbGpPWpGaD
Canagliflozin—UGT1A9—PPARA activates gene expression—EP300—alcohol dependence	0.000202	0.00113	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000199	0.00112	CbGpPWpGaD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000197	0.00111	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—MAOA—alcohol dependence	0.000195	0.0011	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—MAOA—alcohol dependence	0.000195	0.0011	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT2—alcohol dependence	0.000195	0.00109	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADH1A—alcohol dependence	0.00019	0.00107	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—CYP2E1—alcohol dependence	0.000183	0.00103	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000174	0.000974	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GGT1—alcohol dependence	0.000168	0.000944	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT1—alcohol dependence	0.000168	0.000944	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000165	0.000925	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADH4—alcohol dependence	0.000162	0.000906	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000154	0.000861	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—MAOA—alcohol dependence	0.000151	0.000846	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000145	0.000816	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.00014	0.000787	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.00014	0.000785	CbGpPWpGaD
Canagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000139	0.000782	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000139	0.000781	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000138	0.000773	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADH7—alcohol dependence	0.000137	0.000771	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000136	0.000762	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000135	0.000755	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GGT2—alcohol dependence	0.000132	0.000739	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000131	0.000732	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—POMC—alcohol dependence	0.000127	0.000713	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—POMC—alcohol dependence	0.000127	0.000713	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ADH1B—alcohol dependence	0.00012	0.000676	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.00012	0.000675	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADH6—alcohol dependence	0.00012	0.000673	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000114	0.000642	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000114	0.000639	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000113	0.000634	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000112	0.000629	CbGpPWpGaD
Canagliflozin—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000111	0.00062	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADH6—alcohol dependence	0.000105	0.00059	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000103	0.000577	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—EP300—alcohol dependence	0.000101	0.000565	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—EP300—alcohol dependence	0.000101	0.000565	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MAOB—alcohol dependence	9.98e-05	0.00056	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADH1A—alcohol dependence	9.95e-05	0.000558	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—POMC—alcohol dependence	9.82e-05	0.000551	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—MAOA—alcohol dependence	9.23e-05	0.000517	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADH1A—alcohol dependence	8.72e-05	0.000489	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ALDH2—alcohol dependence	8.49e-05	0.000476	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADH4—alcohol dependence	8.46e-05	0.000474	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—EP300—alcohol dependence	8.44e-05	0.000473	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—EP300—alcohol dependence	8.44e-05	0.000473	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	8.16e-05	0.000458	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADH4—alcohol dependence	7.41e-05	0.000416	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	7.39e-05	0.000415	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.32e-05	0.000411	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT2—alcohol dependence	7.22e-05	0.000405	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADH7—alcohol dependence	7.19e-05	0.000403	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT2—alcohol dependence	6.9e-05	0.000387	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—CYP2E1—alcohol dependence	6.79e-05	0.000381	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—EP300—alcohol dependence	6.52e-05	0.000365	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH6—alcohol dependence	6.48e-05	0.000364	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	6.48e-05	0.000363	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ADH1B—alcohol dependence	6.31e-05	0.000354	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADH7—alcohol dependence	6.3e-05	0.000353	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GGT1—alcohol dependence	6.23e-05	0.000349	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT1—alcohol dependence	6.23e-05	0.000349	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AVP—alcohol dependence	6.11e-05	0.000343	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT2—alcohol dependence	6.04e-05	0.000339	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.01e-05	0.000337	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	5.95e-05	0.000334	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—MAOA—alcohol dependence	5.58e-05	0.000313	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ADH1B—alcohol dependence	5.53e-05	0.00031	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	5.41e-05	0.000304	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.37e-05	0.000301	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	5.36e-05	0.0003	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MAOB—alcohol dependence	5.23e-05	0.000293	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MAOB—alcohol dependence	4.58e-05	0.000257	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH4—alcohol dependence	4.57e-05	0.000256	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ALDH2—alcohol dependence	4.44e-05	0.000249	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.27e-05	0.00024	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ALDH2—alcohol dependence	3.89e-05	0.000218	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH7—alcohol dependence	3.88e-05	0.000218	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT2—alcohol dependence	3.78e-05	0.000212	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT2—alcohol dependence	3.72e-05	0.000209	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—POMC—alcohol dependence	3.63e-05	0.000204	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—CYP2E1—alcohol dependence	3.55e-05	0.000199	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.41e-05	0.000191	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT2—alcohol dependence	3.31e-05	0.000186	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT1—alcohol dependence	3.26e-05	0.000183	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT1—alcohol dependence	3.26e-05	0.000183	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—EP300—alcohol dependence	3.11e-05	0.000175	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.11e-05	0.000175	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—MAOA—alcohol dependence	2.92e-05	0.000164	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT1—alcohol dependence	2.86e-05	0.00016	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT1—alcohol dependence	2.86e-05	0.00016	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.83e-05	0.000159	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MAOB—alcohol dependence	2.82e-05	0.000158	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—MAOA—alcohol dependence	2.56e-05	0.000144	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—EP300—alcohol dependence	2.41e-05	0.000135	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.4e-05	0.000135	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT2—alcohol dependence	2.04e-05	0.000114	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—CYP2E1—alcohol dependence	1.92e-05	0.000108	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—POMC—alcohol dependence	1.9e-05	0.000107	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT1—alcohol dependence	1.76e-05	9.87e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT1—alcohol dependence	1.76e-05	9.87e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—POMC—alcohol dependence	1.67e-05	9.35e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—MAOA—alcohol dependence	1.58e-05	8.85e-05	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—EP300—alcohol dependence	1.26e-05	7.08e-05	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—EP300—alcohol dependence	1.11e-05	6.2e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—POMC—alcohol dependence	1.03e-05	5.76e-05	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—EP300—alcohol dependence	6.81e-06	3.82e-05	CbGpPWpGaD
